Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 44 entries
Sorted by: Best Match Show Resources per page
[Prevalence of asymptomatic atherothrombotic lesions and risk of vascular events in patients with documented coronary artery disease].

Archives des maladies du coeur et des vaisseaux

Collet JP, Allali Y, Borentain M, Payot L, Raoux F, Cacoub P, Leys D, Alperovitch A, Montalescot G.
PMID: 16294557
Arch Mal Coeur Vaiss. 2005 Oct;98:31-54.

Coronary arteries are the most frequent location of atherosclerosis. Coronary artery disease is the first cause of death related to atherothrombosis. In addition, patients with a prior history of acute coronary syndromes exhibit a 10% annual risk of recurrence....

Cite
Collet JP, Allali Y, Borentain M, et al. Prévalence des lésions athérothrombotiques asymptomatiques et risques d'evénements vasculaires chez des patients ayant une maladie coronaire documentée. [Prevalence of asymptomatic atherothrombotic lesions and risk of vascular events in patients with documented coronary artery disease]. Arch Mal Coeur Vaiss. 2005;98:31-54
Collet, J. P., Allali, Y., Borentain, M., Payot, L., Raoux, F., Cacoub, P., Leys, D., Alperovitch, A., Montalescot, G. (2005). Prévalence des lésions athérothrombotiques asymptomatiques et risques d'evénements vasculaires chez des patients ayant une maladie coronaire documentée. [Prevalence of asymptomatic atherothrombotic lesions and risk of vascular events in patients with documented coronary artery disease]. Archives des maladies du coeur et des vaisseaux, 9831-54.
Collet, J P, et al. "Prévalence des lésions athérothrombotiques asymptomatiques et risques d'evénements vasculaires chez des patients ayant une maladie coronaire documentée." [Prevalence of asymptomatic atherothrombotic lesions and risk of vascular events in patients with documented coronary artery disease]. Archives des maladies du coeur et des vaisseaux vol. 98 (2005): 31-54.
Collet JP, Allali Y, Borentain M, Payot L, Raoux F, Cacoub P, Leys D, Alperovitch A, Montalescot G. Prévalence des lésions athérothrombotiques asymptomatiques et risques d'evénements vasculaires chez des patients ayant une maladie coronaire documentée. [Prevalence of asymptomatic atherothrombotic lesions and risk of vascular events in patients with documented coronary artery disease]. Arch Mal Coeur Vaiss. 2005 Oct;98:31-54. French. PMID: 16294557.
Copy Download .nbib Format: NLM
2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome.

European cardiology

Tan JWC, Chew DP, Brieger D, Eikelboom J, Montalescot G, Ako J, Kim BK, Quek DK, Aitken SJ, Chow CK, Chour S, Tse HF, Kaul U, Firdaus I, Kubo T, Liew BW, Chong TT, Sin KY, Yeh HI, Buddhari W, Chunhamaneewat N, Hasan F, Fox KA, Nguyen QN, Lo ST.
PMID: 34249148
Eur Cardiol. 2021 Jun 18;16:e26. doi: 10.15420/ecr.2020.45. eCollection 2021 Feb.

The unique characteristics of patients with chronic coronary syndrome (CCS) in the Asia-Pacific region, heterogeneous approaches because of differences in accesses and resources and low number of patients from the Asia-Pacific region in pivotal studies, mean that international guidelines...

Cite
Tan JWC, Chew DP, Brieger D, et al. 2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome. Eur Cardiol. 2021;16:e26doi: 10.15420/ecr.2020.45.
Tan, J. W. C., Chew, D. P., Brieger, D., Eikelboom, J., Montalescot, G., Ako, J., Kim, B. K., Quek, D. K., Aitken, S. J., Chow, C. K., Chour, S., Tse, H. F., Kaul, U., Firdaus, I., Kubo, T., Liew, B. W., Chong, T. T., Sin, K. Y., Yeh, H. I., Buddhari, W., Chunhamaneewat, N., Hasan, F., Fox, K. A., Nguyen, Q. N., & Lo, S. T. (2021). 2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome. European cardiology, 16e26. https://doi.org/10.15420/ecr.2020.45
Tan, Jack Wei Chieh, et al. "2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome." European cardiology vol. 16 (2021): e26. doi: https://doi.org/10.15420/ecr.2020.45
Tan JWC, Chew DP, Brieger D, Eikelboom J, Montalescot G, Ako J, Kim BK, Quek DK, Aitken SJ, Chow CK, Chour S, Tse HF, Kaul U, Firdaus I, Kubo T, Liew BW, Chong TT, Sin KY, Yeh HI, Buddhari W, Chunhamaneewat N, Hasan F, Fox KA, Nguyen QN, Lo ST. 2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome. Eur Cardiol. 2021 Jun 18;16:e26. doi: 10.15420/ecr.2020.45. eCollection 2021 Feb. PMID: 34249148; PMCID: PMC8251506.
Copy Download .nbib Format: NLM
Suicidal Behaviors in Women With the Hypermobile Ehlers-Danlos Syndrome.

Archives of suicide research : official journal of the International Academy for Suicide Research

Baeza-Velasco C, Hamonet C, Montalescot L, Courtet P.
PMID: 33596399
Arch Suicide Res. 2021 Feb 17;1-13. doi: 10.1080/13811118.2021.1885538. Epub 2021 Feb 17.

BACKGROUND: Hypermobile Ehlers-Danlos syndrome (hEDS) is the most frequent heritable disorder of the connective tissue. This is characterized by a generalized fragility of tissues leading to chronic pain, disability and high levels of psychological distress. Suicidal behaviors in those...

Cite
Baeza-Velasco C, Hamonet C, Montalescot L, et al. Suicidal Behaviors in Women With the Hypermobile Ehlers-Danlos Syndrome. Arch Suicide Res. 2021;1-13doi: 10.1080/13811118.2021.1885538.
Baeza-Velasco, C., Hamonet, C., Montalescot, L., & Courtet, P. (2021). Suicidal Behaviors in Women With the Hypermobile Ehlers-Danlos Syndrome. Archives of suicide research : official journal of the International Academy for Suicide Research, 1-13. https://doi.org/10.1080/13811118.2021.1885538
Baeza-Velasco, Carolina, et al. "Suicidal Behaviors in Women With the Hypermobile Ehlers-Danlos Syndrome." Archives of suicide research : official journal of the International Academy for Suicide Research vol. (2021): 1-13. doi: https://doi.org/10.1080/13811118.2021.1885538
Baeza-Velasco C, Hamonet C, Montalescot L, Courtet P. Suicidal Behaviors in Women With the Hypermobile Ehlers-Danlos Syndrome. Arch Suicide Res. 2021 Feb 17;1-13. doi: 10.1080/13811118.2021.1885538. Epub 2021 Feb 17. PMID: 33596399.
Copy Download .nbib Format: NLM
Patients' experience one year after dialysis initiation: a lexicometric analysis.

Health psychology and behavioral medicine

Montalescot L, Rascle N, Combe C, Untas A.
PMID: 34104566
Health Psychol Behav Med. 2021 Apr 30;9(1):380-397. doi: 10.1080/21642850.2021.1918552.

BACKGROUND: Dialysis implies huge changes in patients' lives. Yet, there is a need to better understand patients' experience in the time following dialysis initiation.OBJECTIVE: The objective of this study was to investigate patients' experience of dialysis a year after...

Cite
Montalescot L, Rascle N, Combe C, et al. Patients' experience one year after dialysis initiation: a lexicometric analysis. Health Psychol Behav Med. 2021;9(1):380-397doi: 10.1080/21642850.2021.1918552.
Montalescot, L., Rascle, N., Combe, C., & Untas, A. (2021). Patients' experience one year after dialysis initiation: a lexicometric analysis. Health psychology and behavioral medicine, 9(1), 380-397. https://doi.org/10.1080/21642850.2021.1918552
Montalescot, Lucile, et al. "Patients' experience one year after dialysis initiation: a lexicometric analysis." Health psychology and behavioral medicine vol. 9,1 (2021): 380-397. doi: https://doi.org/10.1080/21642850.2021.1918552
Montalescot L, Rascle N, Combe C, Untas A. Patients' experience one year after dialysis initiation: a lexicometric analysis. Health Psychol Behav Med. 2021 Apr 30;9(1):380-397. doi: 10.1080/21642850.2021.1918552. PMID: 34104566; PMCID: PMC8158193.
Copy Download .nbib Format: NLM
2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitations.

European heart journal. Cardiovascular pharmacotherapy

Zeitouni M, Sabouret P, Kerneis M, Silvain J, Collet JP, Bruckert E, Montalescot G.
PMID: 32652000
Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):324-333. doi: 10.1093/ehjcvp/pvaa077.

In 2019, the European Society of Cardiology and European Atherosclerosis Society released a new guideline document with substantial changes regarding the assessment of cardiovascular risk and treatments. The update of high-risk criteria and categories led to a better detection...

Cite
Zeitouni M, Sabouret P, Kerneis M, et al. 2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitations. Eur Heart J Cardiovasc Pharmacother. 2021;7(4):324-333doi: 10.1093/ehjcvp/pvaa077.
Zeitouni, M., Sabouret, P., Kerneis, M., Silvain, J., Collet, J. P., Bruckert, E., & Montalescot, G. (2021). 2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitations. European heart journal. Cardiovascular pharmacotherapy, 7(4), 324-333. https://doi.org/10.1093/ehjcvp/pvaa077
Zeitouni, Michel, et al. "2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitations." European heart journal. Cardiovascular pharmacotherapy vol. 7,4 (2021): 324-333. doi: https://doi.org/10.1093/ehjcvp/pvaa077
Zeitouni M, Sabouret P, Kerneis M, Silvain J, Collet JP, Bruckert E, Montalescot G. 2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitations. Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):324-333. doi: 10.1093/ehjcvp/pvaa077. PMID: 32652000.
Copy Download .nbib Format: NLM
Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysis.

European heart journal. Cardiovascular pharmacotherapy

Guedeney P, Sorrentino S, Giustino G, Chapelle C, Laporte S, Claessen BE, Ollier E, Camaj A, Kalkman DN, Vogel B, De Rosa S, Indolfi C, Lattuca B, Zeitouni M, Kerneis M, Silvain J, Collet JP, Mehran R, Montalescot G.
PMID: 32275743
Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):225-235. doi: 10.1093/ehjcvp/pvaa024.

AIMS: Although alirocumab and evolocumab have both been associated with improved outcomes in patients with dyslipidaemia or established atherosclerotic cardiovascular disease, data on their respective performances are scarce. This study aimed at providing an indirect comparison of the efficacy...

Cite
Guedeney P, Sorrentino S, Giustino G, et al. Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2021;7(3):225-235doi: 10.1093/ehjcvp/pvaa024.
Guedeney, P., Sorrentino, S., Giustino, G., Chapelle, C., Laporte, S., Claessen, B. E., Ollier, E., Camaj, A., Kalkman, D. N., Vogel, B., De Rosa, S., Indolfi, C., Lattuca, B., Zeitouni, M., Kerneis, M., Silvain, J., Collet, J. P., Mehran, R., & Montalescot, G. (2021). Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysis. European heart journal. Cardiovascular pharmacotherapy, 7(3), 225-235. https://doi.org/10.1093/ehjcvp/pvaa024
Guedeney, Paul, et al. "Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysis." European heart journal. Cardiovascular pharmacotherapy vol. 7,3 (2021): 225-235. doi: https://doi.org/10.1093/ehjcvp/pvaa024
Guedeney P, Sorrentino S, Giustino G, Chapelle C, Laporte S, Claessen BE, Ollier E, Camaj A, Kalkman DN, Vogel B, De Rosa S, Indolfi C, Lattuca B, Zeitouni M, Kerneis M, Silvain J, Collet JP, Mehran R, Montalescot G. Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):225-235. doi: 10.1093/ehjcvp/pvaa024. PMID: 32275743.
Copy Download .nbib Format: NLM
Association of Culprit Lesion Location With Outcomes of Culprit-Lesion-Only vs Immediate Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock: A Post Hoc Analysis of a Randomized Clinical Trial.

JAMA cardiology

Farhan S, Vogel B, Montalescot G, Barthelemy O, Zeymer U, Desch S, de Waha-Thiele S, Maier LS, Sandri M, Akin I, Fuernau G, Ouarrak T, Hauguel-Moreau M, Schneider S, Thiele H, Huber K.
PMID: 32845312
JAMA Cardiol. 2020 Dec 01;5(12):1329-1337. doi: 10.1001/jamacardio.2020.3377.

IMPORTANCE: Myocardial infarction with a culprit lesion located in the left main or proximal left anterior descending artery compared with other coronary segments is associated with more myocardium at risk and worse clinical outcomes.OBJECTIVE: To evaluate the association of...

Cite
Farhan S, Vogel B, Montalescot G, et al. Association of Culprit Lesion Location With Outcomes of Culprit-Lesion-Only vs Immediate Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock: A Post Hoc Analysis of a Randomized Clinical Trial. JAMA Cardiol. 2020;5(12):1329-1337doi: 10.1001/jamacardio.2020.3377.
Farhan, S., Vogel, B., Montalescot, G., Barthelemy, O., Zeymer, U., Desch, S., de Waha-Thiele, S., Maier, L. S., Sandri, M., Akin, I., Fuernau, G., Ouarrak, T., Hauguel-Moreau, M., Schneider, S., Thiele, H., & Huber, K. (2020). Association of Culprit Lesion Location With Outcomes of Culprit-Lesion-Only vs Immediate Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock: A Post Hoc Analysis of a Randomized Clinical Trial. JAMA cardiology, 5(12), 1329-1337. https://doi.org/10.1001/jamacardio.2020.3377
Farhan, Serdar, et al. "Association of Culprit Lesion Location With Outcomes of Culprit-Lesion-Only vs Immediate Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock: A Post Hoc Analysis of a Randomized Clinical Trial." JAMA cardiology vol. 5,12 (2020): 1329-1337. doi: https://doi.org/10.1001/jamacardio.2020.3377
Farhan S, Vogel B, Montalescot G, Barthelemy O, Zeymer U, Desch S, de Waha-Thiele S, Maier LS, Sandri M, Akin I, Fuernau G, Ouarrak T, Hauguel-Moreau M, Schneider S, Thiele H, Huber K. Association of Culprit Lesion Location With Outcomes of Culprit-Lesion-Only vs Immediate Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock: A Post Hoc Analysis of a Randomized Clinical Trial. JAMA Cardiol. 2020 Dec 01;5(12):1329-1337. doi: 10.1001/jamacardio.2020.3377. PMID: 32845312; PMCID: PMC7450400.
Copy Download .nbib Format: NLM
The Enduring Legacy of Failed Revascularization Trials.

Journal of the American College of Cardiology

Dauerman HL, Tijssen JGP, Montalescot G.
PMID: 34736564
J Am Coll Cardiol. 2021 Nov 09;78(19):1886-1889. doi: 10.1016/j.jacc.2021.08.059.

No abstract available.

Cite
Dauerman HL, Tijssen JGP, Montalescot G. The Enduring Legacy of Failed Revascularization Trials. J Am Coll Cardiol. 2021;78(19):1886-1889doi: 10.1016/j.jacc.2021.08.059.
Dauerman, H. L., Tijssen, J. G. P., & Montalescot, G. (2021). The Enduring Legacy of Failed Revascularization Trials. Journal of the American College of Cardiology, 78(19), 1886-1889. https://doi.org/10.1016/j.jacc.2021.08.059
Dauerman, Harold L, et al. "The Enduring Legacy of Failed Revascularization Trials." Journal of the American College of Cardiology vol. 78,19 (2021): 1886-1889. doi: https://doi.org/10.1016/j.jacc.2021.08.059
Dauerman HL, Tijssen JGP, Montalescot G. The Enduring Legacy of Failed Revascularization Trials. J Am Coll Cardiol. 2021 Nov 09;78(19):1886-1889. doi: 10.1016/j.jacc.2021.08.059. PMID: 34736564.
Copy Download .nbib Format: NLM
Life-threatening and major cardiac events during long-distance races: updates from the prospective RACE PARIS registry with a systematic review and meta-analysis.

European journal of preventive cardiology

Gerardin B, Guedeney P, Bellemain-Appaix A, Levasseur T, Mustafic H, Benamer H, Monsegu J, Lamhaut L, Montalescot G, Aubry P, Collet JP.
PMID: 32718236
Eur J Prev Cardiol. 2020 Jul 27;2047487320943001. doi: 10.1177/2047487320943001. Epub 2020 Jul 27.

AIMS: Limited data exist regarding the incidence and aetiology of life-threatening events such as major cardiac events or exertional heat stroke during long-distance races. We aimed to provide an updated incidence, etiology and prognosis of life-threatening events during long-distance...

Cite
Gerardin B, Guedeney P, Bellemain-Appaix A, et al. Life-threatening and major cardiac events during long-distance races: updates from the prospective RACE PARIS registry with a systematic review and meta-analysis. Eur J Prev Cardiol. 2020;2047487320943001doi: 10.1177/2047487320943001.
Gerardin, B., Guedeney, P., Bellemain-Appaix, A., Levasseur, T., Mustafic, H., Benamer, H., Monsegu, J., Lamhaut, L., Montalescot, G., Aubry, P., Collet, J. P. (2020). Life-threatening and major cardiac events during long-distance races: updates from the prospective RACE PARIS registry with a systematic review and meta-analysis. European journal of preventive cardiology, 2047487320943001. https://doi.org/10.1177/2047487320943001
Gerardin, Benoît, et al. "Life-threatening and major cardiac events during long-distance races: updates from the prospective RACE PARIS registry with a systematic review and meta-analysis." European journal of preventive cardiology vol. (2020): 2047487320943001. doi: https://doi.org/10.1177/2047487320943001
Gerardin B, Guedeney P, Bellemain-Appaix A, Levasseur T, Mustafic H, Benamer H, Monsegu J, Lamhaut L, Montalescot G, Aubry P, Collet JP. Life-threatening and major cardiac events during long-distance races: updates from the prospective RACE PARIS registry with a systematic review and meta-analysis. Eur J Prev Cardiol. 2020 Jul 27;2047487320943001. doi: 10.1177/2047487320943001. Epub 2020 Jul 27. PMID: 32718236.
Copy Download .nbib Format: NLM
Impact of Center Volume on Outcomes in Myocardial Infarction Complicated by Cardiogenic Shock: A CULPRIT-SHOCK Substudy.

Journal of the American Heart Association

Schrage B, Zeymer U, Montalescot G, Windecker S, Serpytis P, Vrints C, Stepinska J, Savonitto S, Oldroyd KG, Desch S, Fuernau G, Huber K, Noc M, Schneider S, Ouarrak T, Blankenberg S, Thiele H, Clemmensen P.
PMID: 34622680
J Am Heart Assoc. 2021 Oct 19;10(20):e021150. doi: 10.1161/JAHA.120.021150. Epub 2021 Oct 08.

Background Little is known about the impact of center volume on outcomes in acute myocardial infarction complicated by cardiogenic shock. The aim of this study was to investigate the association between center volume, treatment strategies, and subsequent outcome in...

Cite
Schrage B, Zeymer U, Montalescot G, et al. Impact of Center Volume on Outcomes in Myocardial Infarction Complicated by Cardiogenic Shock: A CULPRIT-SHOCK Substudy. J Am Heart Assoc. 2021;10(20):e021150doi: 10.1161/JAHA.120.021150.
Schrage, B., Zeymer, U., Montalescot, G., Windecker, S., Serpytis, P., Vrints, C., Stepinska, J., Savonitto, S., Oldroyd, K. G., Desch, S., Fuernau, G., Huber, K., Noc, M., Schneider, S., Ouarrak, T., Blankenberg, S., Thiele, H., & Clemmensen, P. (2021). Impact of Center Volume on Outcomes in Myocardial Infarction Complicated by Cardiogenic Shock: A CULPRIT-SHOCK Substudy. Journal of the American Heart Association, 10(20), e021150. https://doi.org/10.1161/JAHA.120.021150
Schrage, Benedikt, et al. "Impact of Center Volume on Outcomes in Myocardial Infarction Complicated by Cardiogenic Shock: A CULPRIT-SHOCK Substudy." Journal of the American Heart Association vol. 10,20 (2021): e021150. doi: https://doi.org/10.1161/JAHA.120.021150
Schrage B, Zeymer U, Montalescot G, Windecker S, Serpytis P, Vrints C, Stepinska J, Savonitto S, Oldroyd KG, Desch S, Fuernau G, Huber K, Noc M, Schneider S, Ouarrak T, Blankenberg S, Thiele H, Clemmensen P. Impact of Center Volume on Outcomes in Myocardial Infarction Complicated by Cardiogenic Shock: A CULPRIT-SHOCK Substudy. J Am Heart Assoc. 2021 Oct 19;10(20):e021150. doi: 10.1161/JAHA.120.021150. Epub 2021 Oct 08. PMID: 34622680; PMCID: PMC8751884.
Copy Download .nbib Format: NLM
Life-threatening and major cardiac events during long-distance races: updates from the prospective RACE PARIS registry with a systematic review and meta-analysis.

European journal of preventive cardiology

Gerardin B, Guedeney P, Bellemain-Appaix A, Levasseur T, Mustafic H, Benamer H, Monsegu J, Lamhaut L, Montalescot G, Aubry P, Collet JP.
PMID: 32718236
Eur J Prev Cardiol. 2020 Jul 27;2047487320943001. doi: 10.1177/2047487320943001. Epub 2020 Jul 27.

AIMS: Limited data exist regarding the incidence and aetiology of life-threatening events such as major cardiac events or exertional heat stroke during long-distance races. We aimed to provide an updated incidence, etiology and prognosis of life-threatening events during long-distance...

Cite
Gerardin B, Guedeney P, Bellemain-Appaix A, et al. Life-threatening and major cardiac events during long-distance races: updates from the prospective RACE PARIS registry with a systematic review and meta-analysis. Eur J Prev Cardiol. 2020;2047487320943001doi: 10.1177/2047487320943001.
Gerardin, B., Guedeney, P., Bellemain-Appaix, A., Levasseur, T., Mustafic, H., Benamer, H., Monsegu, J., Lamhaut, L., Montalescot, G., Aubry, P., Collet, J. P. (2020). Life-threatening and major cardiac events during long-distance races: updates from the prospective RACE PARIS registry with a systematic review and meta-analysis. European journal of preventive cardiology, 2047487320943001. https://doi.org/10.1177/2047487320943001
Gerardin, Benoît, et al. "Life-threatening and major cardiac events during long-distance races: updates from the prospective RACE PARIS registry with a systematic review and meta-analysis." European journal of preventive cardiology vol. (2020): 2047487320943001. doi: https://doi.org/10.1177/2047487320943001
Gerardin B, Guedeney P, Bellemain-Appaix A, Levasseur T, Mustafic H, Benamer H, Monsegu J, Lamhaut L, Montalescot G, Aubry P, Collet JP. Life-threatening and major cardiac events during long-distance races: updates from the prospective RACE PARIS registry with a systematic review and meta-analysis. Eur J Prev Cardiol. 2020 Jul 27;2047487320943001. doi: 10.1177/2047487320943001. Epub 2020 Jul 27. PMID: 32718236.
Copy Download .nbib Format: NLM
Outcomes Associated with Respiratory Failure for Patients with Cardiogenic Shock and Acute Myocardial Infarction: A Substudy of the CULPRIT-SHOCK Trial.

Journal of clinical medicine

Rubini Giménez M, Miller PE, Alviar CL, van Diepen S, Granger CB, Montalescot G, Windecker S, Maier L, Serpytis P, Serpytis R, Oldroyd KG, Noc M, Fuernau G, Huber K, Sandri M, de Waha-Thiele S, Schneider S, Ouarrak T, Zeymer U, Desch S, Thiele H.
PMID: 32245139
J Clin Med. 2020 Mar 20;9(3). doi: 10.3390/jcm9030860.

BACKGROUND: Little is known about clinical outcomes of patients with acute myocardial infraction (AMI) complicated by cardiogenic shock (CS) requiring mechanical ventilation (MV). The aim of this study was to identify the characteristics, risk factors, and outcomes associated with...

Cite
Rubini Giménez M, Miller PE, Alviar CL, et al. Outcomes Associated with Respiratory Failure for Patients with Cardiogenic Shock and Acute Myocardial Infarction: A Substudy of the CULPRIT-SHOCK Trial. J Clin Med. 2020;9(3)doi: 10.3390/jcm9030860.
Rubini Giménez, M., Miller, P. E., Alviar, C. L., van Diepen, S., Granger, C. B., Montalescot, G., Windecker, S., Maier, L., Serpytis, P., Serpytis, R., Oldroyd, K. G., Noc, M., Fuernau, G., Huber, K., Sandri, M., de Waha-Thiele, S., Schneider, S., Ouarrak, T., Zeymer, U., Desch, S., & Thiele, H. (2020). Outcomes Associated with Respiratory Failure for Patients with Cardiogenic Shock and Acute Myocardial Infarction: A Substudy of the CULPRIT-SHOCK Trial. Journal of clinical medicine, 9(3), . https://doi.org/10.3390/jcm9030860
Rubini Giménez, Maria, et al. "Outcomes Associated with Respiratory Failure for Patients with Cardiogenic Shock and Acute Myocardial Infarction: A Substudy of the CULPRIT-SHOCK Trial." Journal of clinical medicine vol. 9,3 (2020). doi: https://doi.org/10.3390/jcm9030860
Rubini Giménez M, Miller PE, Alviar CL, van Diepen S, Granger CB, Montalescot G, Windecker S, Maier L, Serpytis P, Serpytis R, Oldroyd KG, Noc M, Fuernau G, Huber K, Sandri M, de Waha-Thiele S, Schneider S, Ouarrak T, Zeymer U, Desch S, Thiele H. Outcomes Associated with Respiratory Failure for Patients with Cardiogenic Shock and Acute Myocardial Infarction: A Substudy of the CULPRIT-SHOCK Trial. J Clin Med. 2020 Mar 20;9(3). doi: 10.3390/jcm9030860. PMID: 32245139; PMCID: PMC7141492.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 44 entries